These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1173722)

  • 1. The effect of niceritrol (pentaerythritoltetranicotinate) on experimental atherosclerosis in cholesterol-fed rabbits at different levels of plasma cholesterol.
    Brattsand R
    Acta Pharmacol Toxicol (Copenh); 1975 Jan; 36(1):39-55. PubMed ID: 1173722
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
    Brattsand R
    Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of niceritrol (pentaerythritoltetranicotinate) on lipid accumulation in aortas of cholesterol-fed rabbits independent of contemporary reduction of serum lipids.
    Brattsand R; Petersen H; Lundholm L
    Atherosclerosis; 1974; 20(3):469-79. PubMed ID: 4373018
    [No Abstract]   [Full Text] [Related]  

  • 4. A nicotinic acid ester and experimental atherosclerosis: no significant effect of treatment with niceritrol (pentaerythritoltetranicotinate) on cholesterol in aorta of rabbits previously fed with cholesterol-enriched diet.
    Stender S; Astrup P; Brattsand R
    Atherosclerosis; 1976; 23(3):503-11. PubMed ID: 1267865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of nicotinic acid compounds in niceritrol-treated rabbits.
    Brattsand R; Harthon L
    Acta Pharmacol Toxicol (Copenh); 1975 Mar; 36(3):203-14. PubMed ID: 124527
    [No Abstract]   [Full Text] [Related]  

  • 6. Subacute administration of pentaerythritoltetranicotinate (Perycit) to man.
    Harthon L; Svedmyr N
    Atherosclerosis; 1974; 20(1):65-8. PubMed ID: 4617581
    [No Abstract]   [Full Text] [Related]  

  • 7. Actions of vitamins A and E and some nicotinic acid derivatives on plasma lipids and on lipid infiltration of aorta in cholesterol-fed rabbits.
    Brattsand R
    Atherosclerosis; 1975; 22(1):47-61. PubMed ID: 1156470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentaerythritoltetranicotinate (Perycit) in the treatment of hypercholesterolaemia.
    Sigroth K
    Acta Med Scand; 1968 Oct; 184(4):269-73. PubMed ID: 5710032
    [No Abstract]   [Full Text] [Related]  

  • 9. The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.
    Nagakawa Y; Orimo H; Harasawa M
    Thromb Res; 1985 Nov; 40(4):543-53. PubMed ID: 4082125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
    Lundholm L; Jacobsson L; Brattsand R; Magnusson O
    Atherosclerosis; 1978 Feb; 29(2):217-39. PubMed ID: 646851
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1975; 22(1):91-101. PubMed ID: 1098680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of chlorpromazine and haloperidol on serum lipid levels and on atherogenesis in cholesterol fed rabbits.
    Saku K; Sasaki J; Arakawa K
    Artery; 1989; 16(3):151-8. PubMed ID: 2730348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flordipine, a calcium channel blocker, which does not influence lipidemia or atherosclerosis in cholesterol-fed rabbits.
    Kritchevsky D; Tepper SA; Klurfeld DM
    Atherosclerosis; 1988 Jan; 69(1):89-92. PubMed ID: 3355610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of a preparation containing unsaturated fatty acids on the course of experimental atherosclerosis in rabbits].
    Angarskaia MA; Sokolova VE; Liubartseva LA
    Farmakol Toksikol; 1972; 35(6):704-7. PubMed ID: 4651805
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of niceritrol on lipid metabolism of aorta in atherosclerotic rats.
    Shirai K; Ishikawa Y; Nishide T; Sasaki N; Murano S; Sato A; Matsuoka N; Saito Y; Yoshida S
    Tohoku J Exp Med; 1984 Jun; 143(2):231-8. PubMed ID: 6474452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on anti-atherosclerotic agents. II. Experimental studies of 1,3-propanediol bis(2-p-chlorophenoxyisobutyrate) (CLY-503) for anti-atherosclerotic agents].
    Nakanishi M; Kobayakawa T; Okada T; Goto K
    Yakugaku Zasshi; 1970 Aug; 90(8):926-32. PubMed ID: 5466166
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of benactyzine and meprobamate on the development of experimental atherosclerosis in rabbits.
    Cuparencu B; Mocan R; Safta L
    Cor Vasa; 1973; 15(2):136-45. PubMed ID: 4717920
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of induced cholesteremia and atherosclerosis in rabbits with cholestyramine, niacin and taurine.
    Burns MJ; Smith EF; Hoff EJ
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):601-8. PubMed ID: 810322
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
    Hamazaki T; Hasunuma K; Kobayashi S; Shishido H; Yano S
    Atherosclerosis; 1985 Apr; 55(1):107-13. PubMed ID: 4004983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.